Lyka Labs Limited — Amphotericin Exporter Profile
Indian Pharmaceutical Exporter · #13 for Amphotericin · $209.2K export value · DGFT Verified
Lyka Labs Limited is the #13 Indian exporter of Amphotericin with $209.2K in export value and 20 verified shipments. Lyka Labs Limited holds a 0.2% market share in Amphotericin exports across 7 countries. The company exports 5 pharmaceutical products worth $3.4M across 5 therapeutic categories.
Lyka Labs Limited — Amphotericin Export Profile: Buyers & Destinations
Where Does Lyka Labs Limited Export Amphotericin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| KENYA | $56.7K | 3 | 27.8% |
| PERU | $34.0K | 7 | 16.7% |
| VIETNAM | $28.4K | 2 | 13.9% |
| VIETNAM, DEMOCRATIC REP. OF | $28.3K | 2 | 13.9% |
| BANGLADESH | $27.0K | 1 | 13.2% |
| VIETNAM DEMOCRATIC REP. OF | $24.0K | 2 | 11.7% |
| PHILIPPINES | $5.6K | 1 | 2.8% |
| UNITED ARAB EMIRATES | $74 | 1 | 0.0% |
| IRAN | $0 | 1 | 0.0% |
Lyka Labs Limited exports Amphotericin to 9 countries. The largest destination is KENYA accounting for 27.8% of Lyka Labs Limited's Amphotericin shipments, followed by PERU (16.7%) and VIETNAM (13.9%). These destinations reflect Lyka Labs Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Amphotericin from Lyka Labs Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| HARLEYS LIMITED | KENYA | $56.7K | 3 |
| CENTRAL PHARMACEUTICALS JOINT | VIETNAM, DEMOCRATIC REP. OF | $28.3K | 2 |
| JANATA BANK LIMITED | BANGLADESH | $27.0K | 1 |
| NORDIC PHARMACEUTICAL COMPANY SAC | PERU | $24.7K | 5 |
| CENTRAL PHARMACEUTICAL | VIETNAM DEMOCRATIC REP. OF | $24.0K | 2 |
| CENTRAL PHARMACEUTICALS | VIETNAM | $14.3K | 1 |
| CENTRAL PHARMACEUTICALS JOINT STOCK CO | VIETNAM | $14.1K | 1 |
| NORDIC PHARMACEUTICAL CO SAC | PERU | $9.3K | 2 |
| AMBICA INTERNATIONAL CORPORATION | PHILIPPINES | $5.6K | 1 |
| HNL GENERAL TRADING LLC | UNITED ARAB EMIRATES | $74 | 1 |
Lyka Labs Limited supplies Amphotericin to 11 buyers globally. The largest buyer is HARLEYS LIMITED (KENYA), followed by CENTRAL PHARMACEUTICALS JOINT (VIETNAM, DEMOCRATIC REP. OF) and JANATA BANK LIMITED (BANGLADESH). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Amphotericin Export Value and How Much Does Lyka Labs Limited Contribute?
India exported $28.0M worth of Amphotericin through 1,226 shipments from 180 suppliers to 116 countries, serving 390 buyers globally. Lyka Labs Limited contributes $209.2K to this total, accounting for 0.2% of India's Amphotericin exports. Lyka Labs Limited ships Amphotericin to 9 countries through 11 buyers.
What Is the Average Shipment Value for Lyka Labs Limited's Amphotericin Exports?
Lyka Labs Limited's average Amphotericin shipment value is $10.5K per consignment, based on 20 shipments totaling $209.2K. The largest destination is KENYA (27.8% of Lyka Labs Limited's Amphotericin exports).
How Does Lyka Labs Limited Compare to Other Indian Amphotericin Exporters?
Lyka Labs Limited ranks #13 among 180 Indian Amphotericin exporters with a 0.2% market share. The top 3 exporters are BHARAT SERUMS AND VACCINES LIMITED ($15.8M), EMCURE PHARMACEUTICALS LIMITED ($4.5M), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($3.8M). Lyka Labs Limited processed 20 shipments to 7 destination countries.
What Amphotericin Formulations Does Lyka Labs Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| LIPHOLYN INJECTION 50MG LIPOSOMAL AMPHOTERICIN B BATCH NO CE185E MFG DATE 03 2023 EXP DATE 02 2026 | $50.0K | 1 |
| AMPHOT INJECTION 50MG (AMPHOTERICIN B IN | $41.8K | 5 |
| PHARMACEUTICAL RAW MATERIAL-LIPOSOMAL AMPHOTERICIN B INJECTION 50MG (LYOPHILIZEDINJ. VIALS)*VLS | $27.0K | 1 |
| AMPHOT INJECTION 50MG AMPHOTERICIN B IN | $14.3K | 1 |
| AMPHOT INJECTION 50MG AMPHOTERICIN B INJ. USP 50MG,BATCH NO.CC143E, MANUFACTURING DT-21.09.2023 EXP DT-20.09.2025 | $14.1K | 1 |
| AMPHOT - (AMPHOTERICIN B 50MG INJ.)1SBATCH NO:CC146E MFG DT:20/05/2024 EXPDT: 19/05/2026 | $12.0K | 1 |
| AMPHOT - (AMPHOTERICIN B 50MG INJ.)1S-VIETNAM B.NO:CCI45E MFG DT: 02/2024 EXP DT: 02/2026NOS | $12.0K | 1 |
| AMPHOT (AMPHOTERICIN B 50MG INJ.)1S BATCH NO:CC146E MFG DT:05/2024 EXP DT:04/2026 | $7.5K | 1 |
| AMPHOT INJECTION 50MG AMPHOTERICIN B 5 | $6.7K | 2 |
| AMPHOTERICIN B 50 MG LYOPHILIZED PFI IV | $5.6K | 1 |
Lyka Labs Limited exports 15 distinct Amphotericin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is LIPHOLYN INJECTION 50MG LIPOSOMAL AMPHOTERICIN B BATCH NO CE with 1 shipments worth $50.0K.
How Does Lyka Labs Limited Compare to Nearest Amphotericin Exporters?
Exporters ranked immediately above and below #13 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 7 | BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED | $300.0K | 6 | 4 | $50.0K |
| 10 | LIFECARE INNOVATIONS PRIVATE LIMITED | $250.0K | 5 | 2 | $50.0K |
| 13 | LYKA LABS LIMITED ★ | $209.2K | 20 | 7 | $10.5K |
Lyka Labs Limited ranks #13 among 180 Indian Amphotericin exporters. Average shipment value of $10.5K compared to the market average of $155.4K. The closest competitors by value are BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED and LIFECARE INNOVATIONS PRIVATE LIMITED.
Which Indian Ports Ship Amphotericin Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 352 | 28.7% |
| SAHAR AIR | 345 | 28.1% |
| Bombay Air | 119 | 9.7% |
| DELHI AIR | 65 | 5.3% |
| DELHI AIR CARGO ACC (INDEL4) | 62 | 5.1% |
| NHAVA SHEVA SEA (INNSA1) | 38 | 3.1% |
| Bombay Air Cargo | 31 | 2.5% |
| BANGALORE ACC (INBLR4) | 20 | 1.6% |
About Lyka Labs Limited
Lyka Labs Limited exports 5 products worth $3.4M. Beyond Amphotericin, top products include Vancomycin, Hydrocortisone, Amikacin, Levamisole. View the complete Lyka Labs Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Amphotericin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Amphotericin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Lyka Labs Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 20 individual customs records matching Lyka Labs Limited exporting Amphotericin, covering 15 formulations to 9 countries via 11 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 116+ countries, 390+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Amphotericin Export Data from Lyka Labs Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Lyka Labs Limited's Amphotericin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Lyka Labs Limited
Full Company Profile →
5 products · $3.4M total trade · 5 categories
Amphotericin Stats
Company Overview
Top Products by Lyka Labs Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Lyka Labs Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Amphotericin. For current shipment-level data, contact TransData Nexus.